{
    "Trade/Device Name(s)": [
        "FluChip-8G Influenza A + B Assay"
    ],
    "Submitter Information": "InDevR, Inc.",
    "510(k) Number": "K182513",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OZE",
        "NSU",
        "OEP",
        "OQW"
    ],
    "Summary Letter Date": "September 11, 2018",
    "Summary Letter Received Date": "September 12, 2018",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3980"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay"
    ],
    "Analyte Class(es)": [
        "virology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Influenza A/H3N2",
        "Influenza A/H1N1pdm09",
        "\"non-seasonal\" influenza A subtypes",
        "Influenza B/Victoria",
        "Influenza B/Yamagata",
        "Hemagglutinin (HA) gene segment",
        "Neuraminidase (NA) gene segment",
        "Matrix (M) gene segment",
        "Non-structural (NS) gene segment",
        "Nucleoprotein (NP) gene segment"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab",
        "Nasal swab"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Multiplex RT-PCR"
    ],
    "Methodologies": [
        "RT-PCR",
        "Molecular detection",
        "Multiplex analysis"
    ],
    "Submission Type(s)": [
        "Assay",
        "In vitro diagnostic test"
    ],
    "Document Summary": "FDA 510(k) summary for FluChip-8G Influenza A + B Assay, a multiplex RT-PCR in vitro diagnostic for detection and differentiation of seasonal and non-seasonal influenza A subtypes and influenza B lineages.",
    "Indications for Use Summary": "Qualitative detection and differentiation of seasonal influenza A/H3N2, A/H1N1pdm09, non-seasonal influenza A subtypes, and genetic lineage of human influenza B viruses (B/Victoria, B/Yamagata) from nasopharyngeal and nasal swabs from patients with respiratory infection symptoms, for use with clinical and epidemiological risk factors.",
    "fda_folder": "Microbiology"
}